Jon Lim

Jon Lim is a Partner who joined F-Prime Capital in 2011 to launch our dedicated efforts in Health IT/Services. His investments include F-Prime Capital’s investments in Liazon (acquired by Towers Watson), VitalWare (acquired by Health Catalyst), PatientPing, Kyruus, US HealthVest, TraceLink, Stride Health, WelbeHealth, Artemis Health, Protenus, WellAir, Benchling, Centivo, BenchSci and Lumere (acquired by Global Healthcare Exchange). Most recently, Jon was a Principal at Polaris Partners, where he was part of the teams that led investments in several Software-as-a-Service companies (Phytel (acquired by IBM), Egnyte, Recurly, and KISSmetrics), as well as in Ocular Therapeutix (NASDAQ: OCUL). Jon began his investing career in 2002 as an Associate at Summit Partners, where his investments include MDVIP (acquired by Procter & Gamble) and Diagnostic Hybrids (acquired by Quidel). Jon also worked previously at Medtronic in their cardiac rhythm and disease management business.

Jon holds an M.B.A. from Harvard Business School and an A.B. in East Asian Studies from Harvard College, where he graduated magna cum laude.